This Bio-IT article discusses why electronic data capture (EDC) for drug trials isn’t happening: ‘…Inadequate technologies, integration challenges, and the fuzzy stance of the FDA are the biggest impediments to EDC that biopharmas see, according to a recent survey by CenterWatch and the Clinical Data Interchange Standards Consortium (CDISC). In contrast, technology vendors believe the major problem is that biopharmas don�t see the value proposition

�The vendors are spending their time talking about ROI [return on investment],� says Kenneth Getz of CenterWatch. �Meanwhile, companies are worrying about the operational issues.�… This seems to parallel the situation for clinical computing software.